|The SPARCL1 sparcl1 (Catalog #MBS9217482) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.
The SPARCL1 sparcl1 product has the following accession number(s) (GI #190194423) (NCBI Accession #NP_001121782.1) (Uniprot Accession #Q14515). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Cellular Location: Secreted, extracellular space, extracellular matrix. Tissue Location: Highly expressed in lymph node, brain, heart, lung, skeletal muscle, ovary, small intestine, and colon, with lower levels in placenta, pancreas, testis, spleen, and thymus, and no expression in kidney, liver, and peripheral blood leukocytes. SPARCL1 also interacts with the following gene(s): COL1A2, COL3A1. Brain Diseases, Breast Neoplasms, Cognition Disorders, Disease Models, Animal, Epilepsy, Fibrosis, Inflammation, Liver Neoplasms, Lung Neoplasms, Neoplasms, Experimental are some of the diseases may be linked to SPARCL1 Antibody (Center) Blocking peptide. Blood, Bone, Brain, Eye, Heart, Lung, Lymph, Nerve, Prostate, Vascular tissues are correlated with this protein.